At Fermanagh Clinics, we frequently hear from patients interested in weight loss injections. Two popular options currently available are Wegovy and Mounjaro. Both treatments have shown promise in helping individuals achieve significant weight loss, but there are key differences between the two.

In this Q&A, we’ll provide a comprehensive comparison of Wegovy and Mounjaro, addressing common questions to help you make an informed decision.

Q: What are Wegovy and Mounjaro?

Wegovy is a weight loss injection containing semaglutide, a GLP-1 receptor agonist. It is designed for long-term weight management and has been shown to be effective in helping individuals reduce their body weight significantly when combined with a healthy diet and exercise.

Mounjaro, on the other hand, contains tirzepatide, a dual GLP-1 and GIP receptor agonist. It works on appetite suppression, blood sugar control, and fat metabolism. Mounjaro has recently gained attention for its potential as a weight loss injection, particularly for individuals with type 2 diabetes.

Q: How do these weight loss injections work?

Wegovy works by reducing your appetite and slowing down digestion. This results in fewer food cravings and helps you feel fuller for longer, which can lead to a reduced calorie intake. The injection is administered once weekly, making it a convenient option for those seeking long-term weight loss support.

Mounjaro also works by suppressing appetite but with the added benefit of dual action on both GLP-1 and GIP receptors. This double mechanism not only helps reduce food intake but also enhances the body’s ability to process insulin, making it especially beneficial for individuals with type 2 diabetes. Like Wegovy, Mounjaro is typically administered as a weekly injection.

Q: Who can use Wegovy or Mounjaro for weight loss?

Wegovy is suitable for adults with a BMI of 30 or higher, or for those with a BMI of 27 or higher who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It is a great option for individuals who are committed to making lifestyle changes but need additional medical support to achieve their weight loss goals.

Mounjaro, while primarily designed for managing type 2 diabetes, has shown significant weight loss benefits in clinical trials. Mounjaro has only, relatively recently, gained attention for its potential in weight loss. It is generally recommended for patients who need both blood sugar control and assistance with weight management.

Q: How effective are Wegovy and Mounjaro for weight loss?

Wegovy has been shown to help individuals lose, on average, about 15% of their body weight over a period of 68 weeks in clinical trials. Many patients experience noticeable weight loss within the first few months of treatment. It is particularly successful when combined with dietary changes and increased physical activity.

Mounjaro, although primarily a diabetes medication, has demonstrated even more impressive weight loss results in some studies. On average, patients lost 15-20% of their body weight when using the highest dose of Mounjaro. These results suggest that Mounjaro may offer an edge in terms of weight loss effectiveness, especially for those with diabetes.

Q: What are the side effects of these weight loss injections?

Wegovy commonly causes mild to moderate side effects such as nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. These side effects are typically temporary and tend to subside as your body adjusts to the medication. Starting with a lower dose and gradually increasing it helps minimise discomfort.

Mounjaro has similar side effects, including nausea, diarrhoea, and stomach pain. Some individuals may also experience reduced appetite and fatigue. As with Wegovy, these side effects are usually temporary and manageable by gradually increasing the dose.

Q: Are there any risks associated with Wegovy or Mounjaro?

Both Wegovy and Mounjaro are considered safe for most patients when prescribed by a healthcare professional, but there are some risks to be aware of. For both medications, there is a potential increased risk of thyroid tumours. Therefore, they are not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Additionally, both medications should be used with caution in patients with a history of pancreatitis or severe gastrointestinal disorders.

It’s essential to discuss your full medical history with your healthcare provider before starting either weight loss injection.

Q: Which weight loss injection is right for me?

The choice between Wegovy and Mounjaro depends on your individual health needs and goals. Wegovy is a good option if you are focused solely on weight loss and do not have diabetes. It is well-suited to individuals who have struggled with traditional weight loss methods and are looking for long-term management of their weight.

If you have type 2 diabetes and are seeking weight loss as part of your treatment plan, Mounjaro may be a better fit. Its dual action on both GLP-1 and GIP receptors offers the added benefit of blood sugar control alongside significant weight reduction. However, it’s important to note that Mounjaro is not currently licensed for weight loss in individuals without diabetes.

Explore the Best Options for You

At Fermanagh Clinics, we recognise that weight loss is a complex and personal journey. Both Wegovy and Mounjaro offer promising solutions for those struggling to achieve and maintain a healthy weight. However, the best choice will depend on your medical history, weight loss goals, and any underlying conditions such as diabetes. Our healthcare professionals are here to provide guidance, assess your eligibility for weight loss injections, and create a tailored plan to help you succeed.

If you’re considering weight loss injections, we encourage you to get in touch or schedule a consultation with us at Fermanagh Clinics. Together, we can explore the most effective treatment options to help you achieve your health goals.

This blog was written on behalf of Fermanagh Clinics by Pharmacy Mentor.